A detailed history of Ameriprise Financial Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 317,301 shares of SRPT stock, worth $37.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
317,301
Previous 308,413 2.88%
Holding current value
$37.1 Million
Previous $48.7 Million 18.67%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $1.11 Million - $1.39 Million
8,888 Added 2.88%
317,301 $39.6 Million
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $8.79 Million - $12.7 Million
77,591 Added 33.62%
308,413 $48.7 Million
Q1 2024

May 15, 2024

SELL
$93.7 - $141.53 $18,177 - $27,456
-194 Reduced 0.08%
230,822 $29.9 Million
Q4 2023

Feb 14, 2024

SELL
$67.31 - $124.76 $35.1 Million - $65.1 Million
-522,189 Reduced 69.33%
231,016 $22.3 Million
Q3 2023

Nov 14, 2023

SELL
$102.5 - $123.59 $1.33 Million - $1.61 Million
-12,988 Reduced 1.7%
753,205 $91.3 Million
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $1.8 Million - $2.66 Million
16,947 Added 2.26%
766,193 $87.7 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $17.7 Million - $23.5 Million
150,748 Added 25.19%
749,246 $103 Million
Q4 2022

Feb 14, 2023

SELL
$100.86 - $132.13 $17.8 Million - $23.4 Million
-176,835 Reduced 22.81%
598,498 $77.6 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $5.65 Million - $8.89 Million
74,573 Added 10.64%
775,333 $85.7 Million
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $17.7 Million - $25 Million
-282,114 Reduced 28.7%
700,760 $52.2 Million
Q1 2022

May 16, 2022

SELL
$63.15 - $90.42 $7.21 Million - $10.3 Million
-114,169 Reduced 10.41%
982,874 $76.8 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $11.9 Million - $15.3 Million
153,594 Added 16.28%
1,097,043 $98.8 Million
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $11.4 Million - $15.9 Million
-172,341 Reduced 15.45%
943,449 $87.6 Million
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $1.7 Million - $2.13 Million
-24,503 Reduced 2.15%
1,115,790 $86.7 Million
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $33 Million - $77.2 Million
-457,038 Reduced 28.61%
1,140,293 $85 Million
Q4 2020

Feb 12, 2021

BUY
$125.56 - $178.74 $6.3 Million - $8.97 Million
50,189 Added 3.24%
1,597,331 $272 Million
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $4.5 Million - $6.1 Million
35,395 Added 2.34%
1,547,142 $217 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $8.84 Million - $16.3 Million
-95,023 Reduced 5.91%
1,511,747 $242 Million
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $16.9 Million - $27 Million
205,465 Added 14.66%
1,606,770 $157 Million
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $27.7 Million - $49.1 Million
361,989 Added 34.83%
1,401,305 $181 Million
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $17.4 Million - $37.5 Million
-238,941 Reduced 18.69%
1,039,316 $78.3 Million
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $14.4 Million - $19.5 Million
128,057 Added 11.13%
1,278,257 $194 Million
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $93.2 Million - $133 Million
873,817 Added 316.16%
1,150,200 $137 Million
Q4 2018

Feb 14, 2019

SELL
$97.32 - $148.76 $6.7 Million - $10.2 Million
-68,847 Reduced 19.94%
276,383 $30.2 Million
Q3 2018

Nov 14, 2018

BUY
$115.31 - $161.51 $2.76 Million - $3.87 Million
23,931 Added 7.45%
345,230 $55.8 Million
Q2 2018

Aug 14, 2018

SELL
$71.74 - $153.69 $21.5 Million - $46 Million
-299,119 Reduced 48.21%
321,299 $42.2 Million
Q1 2018

May 15, 2018

BUY
$54.02 - $82.27 $27.9 Million - $42.5 Million
516,223 Added 495.44%
620,418 $46 Million
Q4 2017

Feb 12, 2018

SELL
$47.64 - $56.75 $232,721 - $277,223
-4,885 Reduced 4.48%
104,195 $5.8 Million
Q3 2017

Nov 07, 2017

BUY
$35.73 - $47.15 $3.9 Million - $5.14 Million
109,080
109,080 $4.95 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.2B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.